Stock Rich List
#1225 on the rich list of 14,452 insiders

Terrance P. Coyne

EVP & CFO at Royalty Pharma. Based in New York, New York.

$132M
in disclosed stock, −$1.8M (−1.38%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1225th of 14,452
Companies held
1
Largest holding
RPRX, 100.0% of total
Latest SEC filing
Nov 16, 2026

What the $132M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Royalty Pharma RPRX
Class E Ordinary Shares
Indirectly (see filing footnote)1,788,777$67.72$121M91.9%Form 4, Aug 7, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
TPC RP, LLC100,000$67.72$6.8M5.1%Form 4, Nov 6, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through Spouse's IRA24,170$67.72$1.6M1.2%Form 4, Nov 16, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through IRA23,270$67.72$1.6M1.2%Form 4, Nov 16, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
TPC RP EPA1 LLC7,122$67.72$482K0.4%Form 4, Nov 4, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Directly1,500$67.72$102K0.1%Form 4, Nov 16, 2026
Royalty Pharma RPRX
Class A Ordinary Shares
Through Spouse1,450$67.72$98K0.1%Form 4, Nov 16, 2026

Share counts are the amounts Terrance P. Coyne reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 17, 2026SoldRPRX14,751$68.30$1.0MView
Nov 17, 2026SoldRPRX9,835$68.30$672KView
Nov 16, 2026SoldRPRX135,249$68.87$9.3MView
Nov 16, 2026SoldRPRX90,165$68.87$6.2MView
Nov 16, 2026SoldRPRX7,122$68.87$490KView
Aug 13, 2026SoldRPRX9,230$58.59$541KView
Aug 13, 2026SoldRPRX1,772$59.14$105KView
May 26, 2026SoldRPRX64,399$53.98$3.5MView
Apr 28, 2026SoldRPRX1,875$49.78$93KView
Apr 28, 2026SoldRPRX32,916$49.78$1.6MView
Apr 1, 2026SoldRPRX32,916$48.33$1.6MView
Apr 1, 2026SoldRPRX1,875$48.33$91KView
Mar 23, 2026SoldRPRX32,916$45.53$1.5MView
Mar 23, 2026SoldRPRX1,875$45.53$85KView
Mar 2, 2026SoldRPRX1,292$46.67$60KView
Mar 2, 2026SoldRPRX10,429$47.01$490KView
Mar 2, 2026SoldRPRX22,487$46.67$1.0MView
Mar 2, 2026SoldRPRX583$47.01$27KView
Feb 23, 2026SoldRPRX32,916$45.32$1.5MView
Feb 23, 2026SoldRPRX1,875$45.32$85KView
Feb 4, 2026SoldRPRX1,087$43.29$47KView
Feb 4, 2026SoldRPRX19,076$43.29$826KView
Feb 3, 2026SoldRPRX6,195$42.84$265KView
Feb 3, 2026SoldRPRX108,759$42.84$4.7MView
Feb 2, 2026SoldRPRX5,843$42.08$246KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1222Thomas P. Salice
Director, Mettler-Toledo International
$132M−$2.6M (−1.90%)
1223Marjorie Gershwind
10% owner, MSC Industrial Direct Co.. Melville, NY
$132M−$4.9M (−3.59%)
1224Gregory L. Christopher
Chairman of the Board & CEO, Mueller Industries. Germantown, TN
$132M−$49K (−0.04%)
1225Terrance P. Coyne
EVP & CFO, Royalty Pharma. New York, NY
$132M−$1.8M (−1.38%)
1226Michael R. Haske
Chief Operating Officer, Paylocity Holding. Schaumburg, IL
$132M−$1.4M (−1.07%)
1227Yun Yao
10% owner, Indaptus Therapeutics. New York, NY
$131M−$6.7M (−4.86%)
1228Ben Hakim
President, Pershing Square. New York, NY
$131M−$12.3M (−8.59%)

Other Royalty Pharma insiders

All RPRX insiders

Questions

How much stock does Terrance P. Coyne own?

Terrance P. Coyne holds $131,802,691 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 1225th on the Stock Rich List.

Is this Terrance P. Coyne's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Terrance P. Coyne last buy or sell stock?

The most recent open-market trade on file is a sale of 14,751 RPRX shares on Nov 17, 2026 at $68.30.